Response Genetics IncOver The Counter Market:RGDXQ
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Response Genetics Inc | 40.0 | 0.0x | --- |
Gritstone bio Inc | 3.2M | 0.0x | --- |
Viaderma Inc | 10.7M | 0.0x | --- |
Todos Medical Ltd | 2.1K | 0.0x | --- |
Turnstone Biologics Corp | 10.9M | -0.1x | --- |
TRACON Pharmaceuticals Inc | 100.5K | 0.0x | --- |
Company Information
Response Genetics, Inc. is a life science company. The Company is engaged in the research, development, marketing and sale of pharmacogenomic tests for use in the treatment of cancer. To generate pharmacogenomic information from patient specimens for these tests, the Company uses its own methods for the extraction and analysis of nucleic acids and accessing the genetic information available from each patient sample. The Company's platforms include analysis of single biomarkers using the polymerase chain reaction method, as well as gene interrogation using microarray methods and fluorescence in situ hybridization (FISH) from paraffin or frozen tissue specimens. The Company is engaged in selling ResponseDX diagnostic testing products. The Company provides pharmacogenomic clinical trial testing services to pharmaceutical companies in the United States, Asia and Europe.
Contact Information
- Headquarters
- 1640 Marengo St Fl 7thLOS ANGELES, CA, United States 90033-1057
- Phone
- 323-224-3900
- Fax
- 323-224-3096
Executives
- Chairman of the Board, Chief Executive Officer
- Thomas Bologna
- Chief Financial Officer, Vice President
- Kevin Harris
- General Counsel
- Adanech Getachew
- Lead Independent Director
- Kirk Calhoun
- Director
- Michael Serruya
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.00 |
|---|---|
Revenue (TTM) | $16.6M |
Shares Outstanding | 38.8M |
Response Genetics Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.37 |
Book Value | $-0.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -79.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
